Your browser doesn't support javascript.
loading
Toxicity Profile of Chimeric Antigen Receptor T-Cell and Bispecific Antibody Therapies in Multiple Myeloma: Pathogenesis, Prevention and Management.
Markouli, Mariam; Ullah, Fauzia; Unlu, Serhan; Omar, Najiullah; Lopetegui-Lia, Nerea; Duco, Marissa; Anwer, Faiz; Raza, Shahzad; Dima, Danai.
Afiliación
  • Markouli M; Department of Internal Medicine, Boston Medical Center, Boston University School of Medicine, Boston, MA 02118, USA.
  • Ullah F; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
  • Unlu S; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
  • Omar N; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
  • Lopetegui-Lia N; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland Clinic, Cleveland, OH 44195, USA.
  • Duco M; Department of Pharmacy, Cleveland Clinic Foundation, Cleveland Clinic, Cleveland, OH 44195, USA.
  • Anwer F; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland Clinic, Cleveland, OH 44195, USA.
  • Raza S; Department of Hematology and Medical Oncology, Taussig Cancer Institute, Cleveland Clinic Foundation, Cleveland Clinic, Cleveland, OH 44195, USA.
  • Dima D; Department of Translational Hematology and Oncology Research, Lerner Research Institute, Cleveland Clinic, Cleveland, OH 44195, USA.
Curr Oncol ; 30(7): 6330-6352, 2023 07 01.
Article en En | MEDLINE | ID: mdl-37504327
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Receptores Quiméricos de Antígenos / Mieloma Múltiple Tipo de estudio: Etiology_studies / Guideline Límite: Humans Idioma: En Revista: Curr Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Anticuerpos Biespecíficos / Receptores Quiméricos de Antígenos / Mieloma Múltiple Tipo de estudio: Etiology_studies / Guideline Límite: Humans Idioma: En Revista: Curr Oncol Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Suiza